Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.23 USD | -0.92% | +0.66% | +57.43% |
Financials (USD)
Sales 2024 * | 1B | Sales 2025 * | 1.17B | Capitalization | 738M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 29M | EV / Sales 2024 * | 0.97 x |
Net Debt 2024 * | 233M | Net Debt 2025 * | 463M | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
55.2
x | P/E ratio 2025 * |
25.5
x | Employees | 1,920 |
Yield 2024 * |
2.63% | Yield 2025 * |
2.6% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | -0.92% | ||
1 week | +0.66% | ||
Current month | +9.16% | ||
1 month | +37.07% | ||
3 months | +49.18% | ||
6 months | +74.12% | ||
Current year | +57.43% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | Feb. 08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 25 M€ | -1.40% | - | |
0.32% | 28 M€ | -0.70% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 18.23 | -0.92% | 108,517 |
24-05-17 | 18.4 | +2.34% | 194,317 |
24-05-16 | 17.98 | -1.48% | 101,517 |
24-05-15 | 18.25 | +0.22% | 148,299 |
24-05-14 | 18.21 | +0.55% | 178,907 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.43% | 745M | |
-11.64% | 79.42B | |
+14.09% | 8.49B | |
-2.64% | 3.23B | |
+15.71% | 1.75B | |
-1.11% | 1.61B | |
-17.54% | 1.36B | |
+0.59% | 1.3B | |
-4.96% | 1.22B | |
+4.11% | 1.11B |
- Stock Market
- Equities
- PAHC Stock